Salugen Announces its Selection to Participate in the Morrison and Foerster Venture Network
Salugen joins premier network of early-stage and growth companies formed by one of the nation's leading law firms

/Nutrition and Vitamins News Articles/ - SAN DIEGO, CA, July 07, 2008 - Salugen, Inc. (www.salugen.com), a life sciences company, announces today that it has been selected to participate in the Morrison and Foerster Venture Network (www.mofo.com). Building upon its graduation from the San Diego CONNECT Springboard Program (www.connect.org), Salugen has been selected to join this Venture Network and will be able to access selected investment funds and corporate strategic partners from Morrison and Foerster's vast network of 300 funds and corporations.

"Salugen, Inc. is one of the few companies we select each year to participate in our premier network," states Terry Moore, Executive Director of the Morrison and Foerster Venture Network. He goes onto say, "More than just understanding our client's business and underlying technology, we also understand the investment community. We help our clients more efficiently and effectively raise capital from our global network of venture capitalists, corporate strategic and private equity investors."

Salugen CEO Brian Meshkin states, "It's difficult to grow an early stage company and we've had our share of challenges. But as our business progresses from commercial pilots to full-scale commercialization, we need partners that can help us navigate those rough waters. We are honored to be associated with the Morrison and Foerster Venture Network."

Press Release Contact Information:

Brian Meshkin
Salugen, Inc.
President
4660 La Jolla Village Drive, Suite 500
San Diego, California
USA 92122
Voice: 877-258-4360
Fax: 877-258-4360
Website: Visit Our Website